The anticancer activity of alpha-tomatine against mammary adenocarcinoma in mice
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F13%3A10188907" target="_blank" >RIV/00179906:_____/13:10188907 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11150/13:10188907
Result on the web
<a href="http://dx.doi.org/10.5507/bp.2013.031" target="_blank" >http://dx.doi.org/10.5507/bp.2013.031</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5507/bp.2013.031" target="_blank" >10.5507/bp.2013.031</a>
Alternative languages
Result language
angličtina
Original language name
The anticancer activity of alpha-tomatine against mammary adenocarcinoma in mice
Original language description
Aim. To evaluate the anticancer effect of alpha-tomatine (i.p.) either alone or in combination with doxorubicin (i.v.) in a mouse tumour model. Methods. We studied the effect of repeated alpha-tomatine (0.1 - 9 mg/kg) and/or doxorubicin (2 mg/kg) on thegrowth and mitotic activity of the solid Ehrlich tumour in vivo, as well as on the survival of the tumour-bearing mice. Results. Monotherapy with alpha-tomatine had a significant dose-dependent anticancer effect which peaked at 1 mg/kg. This was shown byboth slowed tumour growth and reduced tumour cell proliferation. We also provide the first evidence that the combination alpha-tomatine (1 mg/kg) and doxorubicin (2 mg/kg) had a synergistic effect and significantly prolonged the survival of the mice. Neither alpha-tomatine nor doxorubicin influenced the infiltration of tumours with CD3+ lymphocytes; nor were we able to find an in vivo modulation of the key molecules of two regulatory pathways reported in vitro as the principal anti-canc
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
CE - Biochemistry
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/GPP303%2F12%2FP536" target="_blank" >GPP303/12/P536: The Use of Tomatine, a Tomato Alkaloid, in the Therapy of Cancer</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Biomedical Papers
ISSN
1213-8118
e-ISSN
—
Volume of the periodical
157
Issue of the periodical within the volume
2
Country of publishing house
CZ - CZECH REPUBLIC
Number of pages
9
Pages from-to
153-161
UT code for WoS article
000321737100008
EID of the result in the Scopus database
—